Virus Hiv clinical trials

Explore recruiting virus hiv clinical trials.

Recruiting virus hiv studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Virus Hiv trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Immune response to the recombinant Zoster Vaccine in people living with HIV over 50 years of age compared to non-HIV age- and gender-matched controls - Shingr'HIV

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3b, multicenter, single-arm, open-label study evaluating the efficacy, safety, and tolerability of switching to DTG/3TC single tablet regimen administered once daily from a bictegravir/emtricitabine/tenofovir alafenamide single tablet regimen in people living with HIV of at least 50 years of age who are virologically suppressed

Belgium, Italy, Portugal, Austria, Spain, Germany +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

IAVI C110 HIV Vaccine Trial

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A phase 1 Clinical Trial to Evaluate Safety and Immunogenecity of HIV SOSIP v8.2 763 Vaccine in healthy individuals

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2, Open-label, Multicenter, Randomized Study to Evaluate the Persistence, Safety, and Acceptability of Twice Yearly Long-acting Subcutaneous Lenacapavir for HIV Pre-Exposure Prophylaxis (PrEP) in People Who Would Benefit from PrEP

France

Phase II and Phase III (Integrated) EU CTIS Study details

Virus Hiv trials by city

Virus Hiv in Toronto Virus Hiv in Vancouver Virus Hiv in Montreal Virus Hiv in Calgary Virus Hiv in Edmonton Virus Hiv in Ottawa Virus Hiv in Winnipeg Virus Hiv in Quebec City Virus Hiv in Hamilton Virus Hiv in Kitchener Virus Hiv in London Virus Hiv in Halifax Virus Hiv in New York Virus Hiv in Los Angeles Virus Hiv in Chicago Virus Hiv in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease